Document is current
Any future updates will be listed below
-
Authors
D’Onofrio, Valentina
Weis, Luca
Rigon, Leonardo
Ciprietti, Dario
Grassi, Laura Ludovica
Landi, Andrea
Porcaro, Camillo
Tinkhauser, Gerd
Antonini, Angelo
Guerra, Andrea
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 5 November 2025
First Online: 7 December 2025
Competing interests
: The authors declare the following competing interests: A.A. has received honoraria/consultation fees from AbbVie, Bial, Bayer, Stada, Covantec, Ever Pharma, Medscape, Roche, Theravance Biopharma, UCB, and Zambon. AA has also received funding from Horizon 2020—Ministry of Education, University and Research (MIUR), Ministry of Health (MOH). A.G. has received compensation for consultancy and speaker-related activities from Bial, Zambon, STADA; he receives funding from the European Union “Next Generation EU, Mission 4 Component 1, Project code: P20223HHZ8, CUP: C53D23008440001”. G.T. received financial support from Boston Scientific and Medtronic, not related to the present work. Research agreement with RuneLabs is not related to the present work. G.T. receives funding from the Swiss National Science Foundation (project number: PZ00P3_202166) and the Swiss Parkinson Association.
